SCHEMBL163753

SCHEMBL163753

C#CC(O)(c1ccc(OC)cc1)c1ccc(N2CCOCC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.52
KMT2A Q03164 1/20 0.50
MAPT P10636 7/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
RAB9A P51151 1/20 0.49
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 3/20 0.45
HTT P42858 3/20 0.45
PRKDC P78527 1/20 0.44
HTR3E A5X5Y0 1/20 0.44
HTR3B O95264 1/20 0.44
ADRB1 P08588 1/20 0.44
HTR3A P46098 1/20 0.44
HTR3D Q70Z44 1/20 0.44
HTR3C Q8WXA8 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
GAA P10253 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
GSK3B P49841 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27165409 1.00 AKR1C3 (0.52) AKR1C3KMT2AMAPTL3MBTL1RAB9A
SCHEMBL7134286 0.89 MAPT (0.51) AKR1C3KMT2AMAPTL3MBTL1RAB9A
SCHEMBL25954140 0.89 KMT2A (0.41) AKR1C3KMT2AMAPTRAB9AKDM4E
SCHEMBL25954142 0.89 MAPT (0.47) AKR1C3KMT2AMAPTRAB9AKDM4E
SCHEMBL24620659 0.89 MAPT (0.47) AKR1C3KMT2AMAPTRAB9AKDM4E
SCHEMBL16313177 0.88 MAPT (0.50) KMT2AMAPTL3MBTL1RAB9AKDM4E
SCHEMBL2018095 0.88 MAPT (0.50) KMT2AMAPTL3MBTL1RAB9AKDM4E
SCHEMBL1962366 0.86 KMT2A (0.48) KMT2AMAPTL3MBTL1RAB9AKDM4E
SCHEMBL26629621 0.86 AKR1C3 (0.52) AKR1C3KMT2AMAPTL3MBTL1RAB9A
SCHEMBL1333002 0.86 PRKDC (0.43) AKR1C3KMT2AMAPTL3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260070881-A1 Photochromic Indeno-Fused Naphthopyran Compounds, Compositions, and Articles Containing Same TRANSITIONS OPTICAL LTD (IE) 2026-03-12 US disclosed
EP-4581021-A1 PHOTOCHROMIC INDENO-FUSED NAPHTHOPYRAN COMPOUNDS, COMPOSITIONS, AND ARTICLES CONTAINING SAME Transitions Optical, Ltd. (IE) 2025-07-09 EP disclosed
CN-119816488-A Photochromic indeno-fused naphthopyran compounds, compositions and articles containing the same 全视线光学有限公司 2025-04-11 CN disclosed
WO-2024046542-A1 PHOTOCHROMIC INDENO-FUSED NAPHTHOPYRAN COMPOUNDS, COMPOSITIONS, AND ARTICLES CONTAINING SAME TRANSITIONS OPTICAL, LTD. (IE) 2024-03-07 WO disclosed
EP-4289831-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE AND EYEGLASSES Hoya Lens Thailand Ltd. (TH) 2023-12-13 EP disclosed
EP-3898636-B9 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL LTD (IE) 2023-11-08 EP disclosed
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
EP-3898636-B1 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL LTD (IE) 2023-08-30 EP disclosed
WO-2023140186-A1 PHOTOCHROMIC COMPOUND, NAPHTHOL DERIVATIVE, CURABLE COMPOSITION, OPTICAL ARTICLE, LENS, AND EYEGLASSES 株式会社トクヤマ 2023-07-27 WO disclosed
US-20070215844-A1 Chromene Compound TOKUYAMA CORPORATION (JP) 2007-09-20 US disclosed
EP-1214311-B1 NOVEL INDENO-FUSED PHOTOCHROMIC NAPHTHOPYRANS TRANSITIONS OPTICAL INC (US) 2004-09-15 EP disclosed
EP-1097156-B1 PHTOCHROMIC BENZOPYRANO-FUSED NAPHTHOPYRANS TRANSITIONS OPTICAL INC (US) 2002-10-02 EP disclosed
EP-1214311-A1 NOVEL INDENO-FUSED PHOTOCHROMIC NAPHTHOPYRANS TRANSITIONS OPTICAL, INC. (US) 2002-06-19 EP disclosed
US-6353102-B1 FOR OPHTHALMIC LENSES OR CONTACT LENSES PPG INDUSTRIES OHIO, INC. 2002-03-05 US disclosed
US-6296785-B1 OPHTHALMIC AND CONTACT LENSES; WINDOWS, SAFETY GLASS FOR CARS PPG INDUSTRIES OHIO, INC. 2001-10-02 US disclosed
EP-1097156-A2 PHTOCHROMIC BENZOPYRANO-FUSED NAPHTHOPYRANS TRANSITIONS OPTICAL, INC. (US) 2001-05-09 EP disclosed
WO-2001019813-A1 NOVEL INDENO-FUSED PHOTOCHROMIC NAPHTHOPYRANS TRANSITIONS OPTICAL, INC. (US) 2001-03-22 WO disclosed
US-6022495-A FOR OPTICAL APPLICATIONS TRANSITIONS OPTICAL, INC. (US) 2000-02-08 US disclosed
WO-2000002884-A2 PHOTOCHROMIC BENZOPYRANO-FUSED NAPHTHOPYRANS TRANSITIONS OPTICAL, INC. (US) 2000-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260070881-A1 Photochromic Indeno-Fused Naphthopyran Compounds, Compositions, and Articles Containing Same CCND3, MRPS24, AP3S1 AKR1C3 2339/4885KMT2A 3662/4885MAPT 2099/4885
US-20070215844-A1 Chromene Compound CRY2, TYR, CRY1 AKR1C3 1811/4885KMT2A 411/4885MAPT 520/4885
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES NR2E3, CRY1, RPS10 AKR1C3 1484/4885KMT2A 2867/4885MAPT 3015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.